(atdn) protein diet study

AIDS Treatment Data Network (ATDN) Protein diet study
January 1, 1995

Treatment Review #16; January 1995 A protein diet study is looking for a few more people to volunteer. This study will compare normal to restricted protein diets. Participants will be divided into three groups. One group will be HIV+ with T4 cell counts over 500. The second group will be HIV+ with T4 cell counts under 500. The third control group will be HIV- negative. All participants must be weight stable. Participants will be randomly assigned to either the normal or restricted protein diet. Each dietary period will last for five days. The diets are designed to maintain the participant's admission weight. Although the restricted diet contains a lot less protein than that of the Recommended Dietary Allowance, it is an amount which has no known risks associated with it when consumed for five days. Participants will be admitted to the hospital for two five day stays and receive $200 for each stay. This study takes place in New York City. Call The Network if you are interested in participating.

Most Read: Latest Added Related Topics White House LGBT Conference on HIV/AIDS UNITED STATES: White House in Atlanta: LGBT AIDS Conference No more single-theme conferences: global HIV prevention conference planned FHI 360 Senior Scientist Lut Van Damme Receives International Microbicide Conference Lifetime Achievement Award Equatorial Guinea Ministry of Health and Social Welfare and UNICEF Refute Erroneous AIDS Prevalence Figures Photographs from A Day with HIV Now Online Bulgaria urges Libya to investigate AIDS nurses case Engineers enter fight against AIDS in Africa Gilead’s Complera® Non-Inferior to Atripla® Among Treatment-Naive HIV Patients UN chief Ban calls world leaders to end Aids by 2020 Positive living Lawyer: NY man at center of HIV scare not positive Zimbabwe activist: Prisoners denied AIDS drugs Youth organizations form a pact for social transformation in the AIDS response Kingdom of Bahrain and UNAIDS commit to intensify cooperation CANADA: Celibate Homosexual Men Now Allowed to Donate Blood in Canada AFRICA: UN: AIDS Deaths Down, Treatment Up in Africa MICHIGAN: STD Fee for Jackson County Walk-In Clinic Takes Effect June 3 NEW YORK: Catskill Hospital Warns That Insulin Pens May Have Been Reused DELAWARE: Cape Henlopen Theatre Academy to Host 'Magic to Do' May 25 Study Finds Vitamin C Can Kill Drug-Resistant TB CONNECTICUT: Yale Researchers Urge More Street Work When Studying People With Both HIV, Hepatitis C Sangamo BioSciences Presents New Data From In Vivo Protein Replacement Platform For Development Of ZFP Therapeutics® For Monogenic Diseases Researchers from Albert Einstein College of Medicine Report Details of New Studies and Findings in the Area of HIV/AIDS NanoPass Technologies Supports a CDC-Sponsored Phase 3 Study of Polio Vaccine in Infants as Part of its Global Health Initiative Uganda: Breastfeeding Lowers HIV Transmission - Study Study Results from Eunice Kennedy Shriver National Institute of Child Health and Human Development Provide New Insights into HIV/AIDS HIV Vaccine Study Cancelled Less-used drug better treats HIV in kids: study UNITED STATES: Study Suggests PrEP May Not Increase Sexual Risk-Taking in Gay Men
Copyright © 1995 -AIDS Treatment Data Network, Publisher. All rights reserved to AIDS Treatment Data Network. Reproduction of this article (other than one copy for personal reference) must be cleared through the AIDS Treatment Data Network. Email AIDS Treatment Data Network Information in this article was accurate in January 1, 1995. The state of the art may have changed since the publication date. This material is designed to support, not replace, the relationship that exists between you and your doctor. Always discuss treatment options with a doctor who specializes in treating HIV.